These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6431469)

  • 41. Discriminative stimulus effects of S(-)-methcathinone (CAT): a potent stimulant drug of abuse.
    Young R; Glennon RA
    Psychopharmacology (Berl); 1998 Dec; 140(3):250-6. PubMed ID: 9877004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discriminative stimulus properties of the nicotinic agonist cytisine.
    Chandler CJ; Stolerman IP
    Psychopharmacology (Berl); 1997 Feb; 129(3):257-64. PubMed ID: 9084064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discriminative stimulus properties of amphetamine, cathinone, and related agents.
    Goudie AJ
    NIDA Res Monogr; 1991; (116):45-60. PubMed ID: 1369680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation of the discriminative stimulus properties of cocaine: comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists.
    Callahan PM; Cunningham KA
    Neuropharmacology; 1997 Mar; 36(3):373-81. PubMed ID: 9175616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.
    Rothman RB; Baumann MH; Savage JE; Rauser L; McBride A; Hufeisen SJ; Roth BL
    Circulation; 2000 Dec; 102(23):2836-41. PubMed ID: 11104741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inverse agonist properties of the FG 7142 discriminative stimulus.
    Leidenheimer NJ; Schechter MD
    Pharmacol Biochem Behav; 1991 Jan; 38(1):99-104. PubMed ID: 1850137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline.
    Appel JB; Callahan PM
    Eur J Pharmacol; 1989 Jan; 159(1):41-6. PubMed ID: 2707301
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inverse agonist properties of the THBC discriminative stimulus: asymmetrical generalization with FG 7142.
    Leidenheimer NJ; Schechter MD
    Pharmacol Biochem Behav; 1991 Mar; 38(3):519-25. PubMed ID: 1648746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discriminative stimulus properties of the serotonin agonist 1-(3-trifluoromethylphenyl)piperazine (TFMPP).
    Glennon RA; McKenney JD; Young R
    Life Sci; 1984 Oct; 35(14):1475-80. PubMed ID: 6482668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Central 5-hydroxytryptamine2 receptors are involved in the adrenal catecholamine-releasing and hyperglycemic effects of the 5-hydroxytryptamine indirect agonist d-fenfluramine in the conscious rat.
    Chaouloff F; Gunn SH; Young JB
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1008-16. PubMed ID: 1545373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine.
    Gasior M; Shoaib M; Yasar S; Jaszyna M; Goldberg SR
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1053-73. PubMed ID: 10027843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detailed investigations of 5-HT3 compounds in a drug discrimination model.
    De La Garza R; Callahan PM; Cunningham KA
    Pharmacol Biochem Behav; 1996 Jul; 54(3):533-40. PubMed ID: 8743626
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discriminative stimulus properties of pentylenetetrazol and bemegride: some generalization and antagonism tests.
    Shearman G; Lal H
    Psychopharmacology (Berl); 1979 Sep; 64(3):315-9. PubMed ID: 41279
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involvement of 5-hydroxytryptamine 2A (5-HT2A) receptors in the mediation of the discriminative stimulus properties of (+/-)DOI in rats.
    Chojnacka-Wójcik E; Kłodzińska A
    Pol J Pharmacol; 1997; 49(5):299-304. PubMed ID: 9566028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of fluoxetine and d-fenfluramine on cocaine-seeking behavior in rats.
    Burmeister JJ; Lungren EM; Neisewander JL
    Psychopharmacology (Berl); 2003 Jul; 168(1-2):146-154. PubMed ID: 12529808
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Additional evidence that L-5-hydroxytryptophan discrimination models a unique serotonin receptor.
    Friedman R; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 1983; 80(3):209-13. PubMed ID: 6137018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL/6 mice: role of 5-HT(2A) serotonergic and alpha (1) adrenergic antagonism.
    Philibin SD; Walentiny DM; Vunck SA; Prus AJ; Meltzer HY; Porter JH
    Psychopharmacology (Berl); 2009 Apr; 203(2):303-15. PubMed ID: 18989659
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats.
    Sánchez H; Velázquez-Martínez DN
    J Psychopharmacol; 2001 Mar; 15(1):29-36. PubMed ID: 11277605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative cue generalization profiles of L-838, 417, SL651498, zolpidem, CL218,872, ocinaplon, bretazenil, zopiclone, and various benzodiazepines in chlordiazepoxide and zolpidem drug discrimination.
    Mirza NR; Rodgers RJ; Mathiasen LS
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1291-9. PubMed ID: 16339395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.